nach oben

Internal and Emergency Medicine

Erschienen in:

16.08.2018 | IM - COMMENTARY

The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey

verfasst von: Giuseppe Mulè’, Caterina Carollo, Marco Guarneri, Santina Cottone

Erschienen in: Internal and Emergency Medicine | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Excerpt

Atrial fibrillation is the most common sustained cardiac dysrhythmia. It represents a major public health problem due to increased mortality risk, reduced quality of life, and increased health costs [1, 2]. …

Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18:1609–1678CrossRefPubMed

January CT, Wann LS, Alpert JS et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol 64:2245–2280. https://doi.org/10.1016/j.jacc.2014.03.021 CrossRef

Chugh SS, Roth GA, Gillum RF, Mensah GA (2014) Global burden of atrial fibrillation in developed and developing nations. Glob Heart 9:113–119. https://doi.org/10.1016/j.gheart.2014.01.004 CrossRefPubMed

Krijthe BP, Kunst A, Benjamin EJ et al (2013) Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 34:2746–2751. https://doi.org/10.1093/eurheartj/eht280 CrossRefPubMedPubMedCentral

Healey JS, Alings M, Ha A et al (2017) Subclinical atrial fibrillation in older patients. Circulation 136:1276–1283. https://doi.org/10.1161/CIRCULATIONAHA.117.028845 CrossRefPubMed

Ferro D, Loffredo L, Polimeni L, Violi F (2007) Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy. Intern Emerg Med 2:24–28. https://doi.org/10.1007/s11739-007-0005-2 CrossRefPubMedPubMedCentral

Ogilvie IM, Newton N, Welner SA et al (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123:638.e4–645.e4. https://doi.org/10.1016/J.AMJMED.2009.11.025 CrossRef

Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–891. https://doi.org/10.1056/NEJMoa1009638 CrossRefPubMed

Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955–962. https://doi.org/10.1016/S0140-6736(13)62343-0 CrossRefPubMed

10.

Larsen TB, Skjøth F, Nielsen PB et al (2016) Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ 353:i3189. https://doi.org/10.1136/BMJ.I3189 CrossRefPubMedPubMedCentral

11.

Prisco D, Ageno W, Becattini C et al (2017) Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med 12:387–406. https://doi.org/10.1007/s11739-017-1628-6 CrossRefPubMed

12.

Borghi C, Paolillo S, Cicero AFG et al (2017) New oral anticoagulants and prevention of thromboembolic events in patients with hypertension and atrial fibrillation. J Hypertens 35:689–695. https://doi.org/10.1097/HJH.0000000000001228 CrossRefPubMed

13.

Hsu JC, Maddox TM, Kennedy KF et al (2016) Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk. JAMA Cardiol 1:55. https://doi.org/10.1001/jamacardio.2015.0374 CrossRefPubMed

14.

Kjerpeseth LJ, Ellekjær H, Selmer R et al (2017) Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015. Eur J Clin Pharmacol 73:1417–1425. https://doi.org/10.1007/s00228-017-2296-1 CrossRefPubMed

15.

Gülker J-E, Kröger K, Kowall B et al (2018) Increasing use of anticoagulants in Germany and its impact on hospitalization for intracranial bleeding. Circ Cardiovasc Qual Outcomes 11:e004470. https://doi.org/10.1161/CIRCOUTCOMES.117.004470 CrossRefPubMed

16.

Volterrani M, Iellamo F, Alberto C et al (2018) NOAC in “real world” patients with atrial fibrillation in Italy: results from the ISPAF-2 (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study. 2 Intern Emerg Med. https://doi.org/10.1007/s11739-018-1896-9 (in press) CrossRefPubMed

17.

Huisman MV, Rothman KJ, Paquette M et al (2017) The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2. J Am Coll Cardiol 69:777–785. https://doi.org/10.1016/j.jacc.2016.11.061 CrossRefPubMed

Titel: The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey
verfasst von: Giuseppe Mulè’
Caterina Carollo
Marco Guarneri
Santina Cottone
Publikationsdatum: 16.08.2018
Verlag: Springer International Publishing
Erschienen in: Internal and Emergency Medicine / Ausgabe 7/2018
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-018-1929-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Parkinson-Krankheit | Nachrichten

Viel Bewegung in der Parkinsonforschung

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2018

Efficiency of electronic signout for ED-to-inpatient admission at a non-teaching hospital

A focus on direct oral anticoagulants: “old” and possible new indications and efforts for a better clinical management

Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: significant differences between direct oral anticoagulants and vitamin K antagonists

Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients? No

Penile self-amputation

Malarial fevers in the fourteenth century Divine Comedy